Background Nonalcoholic fatty liver disease (NAFLD) is a common liver problem, including
both nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH). In this study …

Background Non-alcoholic steatoheaptitis (NASH), the critical stage of non-alcoholic fatty
liver disease (NAFLD), is of chronic progression and can develop cirrhosis even …

BACKGROUND & AIMS: The diagnosis of non-alcoholic fatty liver disease (NAFLD) and
steatohepatitis (NASH) is limited by the need for liver biopsy. We aimed at testing the …

Background Nonalcoholic fatty liver disease (NAFLD) is one of the critical public health
problems in China. The full spectrum of the disease ranges from simple steatosis and …

Abstract Background and Aims: We identified patients with nonalcoholic fatty liver disease
(NAFLD) to determine the predictive value of serum markers to diagnose histological …

Methods One hundred and eight consecutive patients with biopsy-proven NAFLD (age,
39.8±13.5 years, mean±SD; males, 67.6%) were prospectively enrolled from 10 participating …

Objective Several noninvasive markers have been developed to predict nonalcoholic
steatohepatitis (NASH). We investigated the predictive value of the cytokeratin-18 fragment …

Introduction MACK‐3 (combination of hoMa, Ast and CK18) was reported to be a good
biomarker for the diagnosis of fibrotic non‐alcoholic steatohepatitis (NASH). However, there …

Background Non-alcoholic fatty liver disease (NAFLD) is the most common cause of liver
disease worldwide, with a prevalence of 15%-30% in Western populations. Non-alcoholic …

Background Nonalcoholic fatty liver disease (NAFLD) consists of nonalcoholic fatty liver
(NAFL) and nonalcoholic steatohepatitis (NASH); the latter progresses to liver cirrhosis and …